GlassScriptPhysician profile
Desiree M Howley
NPI 1316472723
$2,057.99
in general payments reported to CMS, 2019-2025
20 companies · $2,014 in 2025
The $2,014 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $14.45 · 2024: $29.24 · 2025: $2,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,057.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $314.25 | 2025 | |
| United Therapeutics Corporation | $249.85 | 2025 | Tyvaso |
| Abbott Laboratories | $180.88 | 2023-2025 | Mitraclip, Proclaim |
| Novartis Pharmaceuticals Corporation | $157.73 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $155.44 | 2025 | Lifevest |
| Merck Sharp & Dohme LLC | $153.26 | 2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.12 | 2025 | Jardiance |
| Edwards Lifesciences Corporation | $135.38 | 2025 | Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $134.54 | 2025 | Amvuttra |
| Esperion Therapeutics, INC. | $87.66 | 2025 | Nexletol |
| Pfizer INC. | $68.75 | 2025 | |
| Scpharmaceuticals INC. | $50.88 | 2025 | |
| Philips North America LLC | $36.93 | 2025 | Extended Holter |
| Bridgebio Pharma, INC. | $36.00 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $31.26 | 2025 | Assure Wcd |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $30.04 | 2025 | Repatha |
| Abiomed | $29.66 | 2025 | |
| Novo Nordisk INC | $29.24 | 2024 | Rybelsus, Ozempic |
| Surmodics, INC. | $19.08 | 2025 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
| Astrazeneca Pharmaceuticals LP | $18.04 | 2025 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desiree Howley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.